These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33319815)

  • 1. T cell signaling and Treg dysfunction correlate to disease kinetics in IL-2Rα-KO autoimmune mice.
    Mullins GN; Valentine KM; Al-Kuhlani M; Davini D; Jensen KDC; Hoyer KK
    Sci Rep; 2020 Dec; 10(1):21994. PubMed ID: 33319815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A regulatory T cell-dependent novel function of CD25 (IL-2Ralpha) controlling memory CD8(+) T cell homeostasis.
    Sharma R; Zheng L; Deshmukh US; Jarjour WN; Sung SS; Fu SM; Ju ST
    J Immunol; 2007 Feb; 178(3):1251-5. PubMed ID: 17237369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of Fas in the immune system biology of IL-2R alpha knockout mice: interplay among regulatory T cells, inflammation, hemopoiesis, and apoptosis.
    Sharma R; Bagavant H; Jarjour WN; Sung SS; Ju ST
    J Immunol; 2005 Aug; 175(3):1965-73. PubMed ID: 16034141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALKS 4230: a novel engineered IL-2 fusion protein with an improved cellular selectivity profile for cancer immunotherapy.
    Lopes JE; Fisher JL; Flick HL; Wang C; Sun L; Ernstoff MS; Alvarez JC; Losey HC
    J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32317293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-2Rα mediates temporal regulation of IL-2 signaling and enhances immunotherapy.
    Su EW; Moore CJ; Suriano S; Johnson CB; Songalia N; Patterson A; Neitzke DJ; Andrijauskaite K; Garrett-Mayer E; Mehrotra S; Paulos CM; Doedens AL; Goldrath AW; Li Z; Cole DJ; Rubinstein MP
    Sci Transl Med; 2015 Oct; 7(311):311ra170. PubMed ID: 26511507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential mechanisms in the pathogenesis of autoimmune cholangitis versus inflammatory bowel disease in interleukin-2Ralpha(-/-) mice.
    Hsu W; Zhang W; Tsuneyama K; Moritoki Y; Ridgway WM; Ansari AA; Coppel RL; Lian ZX; Mackay I; Gershwin ME
    Hepatology; 2009 Jan; 49(1):133-40. PubMed ID: 19065673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to Interleukin-2 Elicit Selective T Cell Subset Potentiation through Distinct Conformational Mechanisms.
    Spangler JB; Tomala J; Luca VC; Jude KM; Dong S; Ring AM; Votavova P; Pepper M; Kovar M; Garcia KC
    Immunity; 2015 May; 42(5):815-25. PubMed ID: 25992858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential and non-overlapping IL-2Rα-dependent processes for thymic development and peripheral homeostasis of regulatory T cells.
    Toomer KH; Lui JB; Altman NH; Ban Y; Chen X; Malek TR
    Nat Commun; 2019 Mar; 10(1):1037. PubMed ID: 30833563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells.
    Bell CJ; Sun Y; Nowak UM; Clark J; Howlett S; Pekalski ML; Yang X; Ast O; Waldhauer I; Freimoser-Grundschober A; Moessner E; Umana P; Klein C; Hosse RJ; Wicker LS; Peterson LB
    J Autoimmun; 2015 Jan; 56():66-80. PubMed ID: 25457307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8
    Gravano DM; Al-Kuhlani M; Davini D; Sanders PD; Manilay JO; Hoyer KK
    J Autoimmun; 2016 Dec; 75():58-67. PubMed ID: 27453063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential modulation by IL-17A of Cholangitis versus Colitis in IL-2Rα deleted mice.
    Yang W; Yao Y; Yang YQ; Lu FT; Li L; Wang YH; Nakajima T; Tsuneyama K; Ridgway WM; Gershwin ME; Lian ZX
    PLoS One; 2014; 9(8):e105351. PubMed ID: 25133396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-1BB Signaling Enhances Primary and Secondary Population Expansion of CD8+ T Cells by Maximizing Autocrine IL-2/IL-2 Receptor Signaling.
    Oh HS; Choi BK; Kim YH; Lee DG; Hwang S; Lee MJ; Park SH; Bae YS; Kwon BS
    PLoS One; 2015; 10(5):e0126765. PubMed ID: 25962156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
    Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA
    Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutting Edge: Differential Fine-Tuning of IL-2- and IL-15-Dependent Functions by Targeting Their Common IL-2/15Rβ/γc Receptor.
    Meghnem D; Morisseau S; Frutoso M; Trillet K; Maillasson M; Barbieux I; Khaddage S; Leray I; Hildinger M; Quéméner A; Jacques Y; Mortier E
    J Immunol; 2017 Jun; 198(12):4563-4568. PubMed ID: 28507024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-10 participates in the expansion and functional activation of CD8
    Pino-Martínez AM; Miranda CG; Batalla EI; González-Cappa SM; Alba Soto CD
    J Leukoc Biol; 2019 Jan; 105(1):163-175. PubMed ID: 30371945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversing tumor immune suppression with intratumoral IL-12: activation of tumor-associated T effector/memory cells, induction of T suppressor apoptosis, and infiltration of CD8+ T effectors.
    Kilinc MO; Aulakh KS; Nair RE; Jones SA; Alard P; Kosiewicz MM; Egilmez NK
    J Immunol; 2006 Nov; 177(10):6962-73. PubMed ID: 17082611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutting edge: mechanisms of IL-2-dependent maintenance of functional regulatory T cells.
    Barron L; Dooms H; Hoyer KK; Kuswanto W; Hofmann J; O'Gorman WE; Abbas AK
    J Immunol; 2010 Dec; 185(11):6426-30. PubMed ID: 21037099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-2 promotes the function of memory-like autoregulatory CD8+ T cells but suppresses their development via FoxP3+ Treg cells.
    Shameli A; Yamanouchi J; Tsai S; Yang Y; Clemente-Casares X; Moore A; Serra P; Santamaria P
    Eur J Immunol; 2013 Feb; 43(2):394-403. PubMed ID: 23180662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prodigiosin blocks T cell activation by inhibiting interleukin-2Ralpha expression and delays progression of autoimmune diabetes and collagen-induced arthritis.
    Han SB; Park SH; Jeon YJ; Kim YK; Kim HM; Yang KH
    J Pharmacol Exp Ther; 2001 Nov; 299(2):415-25. PubMed ID: 11602650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8
    Yao Y; Li L; Yang SH; Gao CY; Liao LH; Xie YQ; Yin XY; Yang YQ; Fei YY; Lian ZX
    J Autoimmun; 2018 May; 89():101-111. PubMed ID: 29307587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.